Biweekly paclitaxel and cisplatin in patients with advanced head and neck carcinoma. A phase II trial

Annals of Oncology

Volumn 8, Issue 11, 1997, Pages 1157-1158

  Licitra, L ^a   Capri, G ^a   Fulfaro, F ^a   Grandi, C ^a   Tarenzi, E ^a   Cavina, R ^a   Gianni, L ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Cisplatin; Head and neck cancer; Paclitaxel

Indexed keywords

CISPLATIN; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; ASTHENIA; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; DRUG RESPONSE; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; MALE; METASTASIS; NEUTROPENIA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PACLITAXEL; PALLIATIVE CARE; TREATMENT OUTCOME;

EID: 0030711563     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008260817878     Document Type: Article

References (9)

1. Hong WK, Bromer R. Chemotherapy in head and neck cancer. N Engl J Med 1983: 308; 75-8.
2. Yokes EE, Athanasiadis I. Chemotherapy for squamous cell carcinoma of head and neck: The future is now. Ann Oncol 1996; 7: 15-29.
3. Jacobs C, Lyman G, Velez-Garcia E et al. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol 1992; 10: 257-63.
4. Forastiere AA. Paclitaxel (taxol) for the treatment of head and neck cancer. Semin Oncol 1994; 21 (Suppl 8): 49-52.
5. Rowinsky EK, Donehower RC. Drug Therapy: Paclitaxel (Taxol). N Engl J Med 1995; 332: 1004-14.
6. O'Reilly SE, Gelmon KA. Biweekly paclitaxel and cisplatin: A phase I/II study in the first-line treatment of metastatic breast cancer. Semin Oncol 1995; 22 (Suppl 6): 109-11.
7. Browman GP, Cronin L. Standard chemotherapy in squamous cell head and neck cancer: What we have learned from randomized trials. Semin Oncol 1994; 21: 311-9.
8. Wasserheit C, Alter R, Speyer J, et al. Phase II trial of paclitaxel and cisplatin (DDP) in women with metastatic breast cancer. Am Soc Med Oncol 1994; 13: 100 (Abstr 204).
9. Forastiere AA, Leong T, Murphy B et al. A phase III trial of high-dose paclitaxel + cisplatin + GCSF versus low-dose paclitaxel + cisplatin in patients with advanced squamous cell carcinoma of the head and neck: An Eastern Cooperative Oncology Group trial. Proc Am Soc Clin Oncol 1997; 16: 384a.